// App-Quantinova.ai

170 : Safety and efficacy of subcutaneous tocilizumab in patients with systemic and polyarticular juvenile idiopathic arthritis

Researchers

Presenter

  • Athimalaipet V Ramanan

Principal Investigators

  • Nicola Ruperto

  • Alberto Martini

  • Rubn J Cuttica

  • Jennifer E Weiss

  • Michael Henrickson

  • Heinrike Schmeling

  • Jordi Antn

  • Kirsten Minden

  • Gerd Horneff

  • Mara Luz Gmir-Gmir

  • Markus Hufnagel

  • Wendy Douglass

  • Chris Wells

  • Sunethra Wimalasundera

  • Navita L Mallalieu

  • Daniel J Lovell

  • Fabrizio De Benedetti

Medical Centers

  • Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, Bristol, UNITED KINGDOM

  • Developmental Biology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

  • Paediatric Rheumatology International Trials Organisation (PRINTO) Coordinating Centre, Genoa, Italy

  • n/a, Hospital Gral de Niños Pedro Elizalde, Buenos Aires, ARGENTINA

  • Hackensack University Medical Center, Oradell, NJ

  • Department of Pediatrics, Alberta Childrens Hospital, University of Calgary, Calgary, AB, Canada

  • Pediatric Rheumatology, Hospital de Sant Joan de Deu, Barcelona, Spain

  • n/a, Charité–Universitätsmedizin Berlin, Berlin, GERMANY

  • Asklepios Clinic Sankt Augustin, and University Hospital of Cologne, Cologne, GERMANY

  • Unidad de Reumatologia Pediatrica, Hospital Ramón y Cajal, Madrid, SPAIN

  • Department of Pediatrics and Adolescent Medicine, University Medical Center, Medical Faculty, University of Freiburg, Freiburg, Germany

  • n/a, Roche Products Ltd., Welwyn Garden City, UNITED KINGDOM

  • Roche Innovation Center, New York, NY

  • Dipartimento di Medicina Pediatrica, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, ITALY

Locations

  • United Kingdom

  • United States

  • Italy

  • Argentina

  • Canada

  • Spain

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

  • Tocilizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02165345

  • NCT01904292

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved